# RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)

> **NCT02471495** · PHASE3 · WITHDRAWN · sponsor: **Medical Enterprises Europe B.V.**

## Conditions studied

- Bladder Cancer

## Interventions

- **DEVICE:** Synergo® RITE + MMC

## Key facts

- **NCT ID:** NCT02471495
- **Lead sponsor:** Medical Enterprises Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-09
- **Primary completion:** 2019-01
- **Final completion:** 2020-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02471495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02471495, "RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02471495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*